In results presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, a collaborative study by the University of Colorado and the National Cancer Institute (NCI) reports that the TERT gene promoter was altered in 69 percent of 54 cases of bladder cancer due to variants that occur after birth (called somatic) and in 56 percent of bladder cancers due to inherited variants … Continue reading Precision medicine study shows the most frequently altered gene in bladder cancer.